The phase 2b study is an open-label trial that will enroll 40 men with advanced prostate cancer who are appropriate candidates for ADT. Participants will receive an initial loading dose of teverelix ...
Supraphysiologic anabolic steroid use is increasing among recreational athletes, causing cardiac, psychiatric, renal, and ...
The Company is developing Teverelix® as a best-in-class market product for advanced prostate cancer patients with high CV ...
BoomRx, the fastest-growing national pharmaceutical technology platform that simplifies prescription sourcing and fulfillment, today announced the availability of an oral liquid testosterone ...
ARSYNL Rx Launches Exclusive HypoSpray® Transdermal Testosterone Option, Marking a New Era in Hormone Support Dover, United States – February 5, 2026 / ARSYNL Rx / ARSYNL Rx, a leader in ...
The U.S. Food and Drug Administration (FDA) recently approved the use of Darzalex Faspro (daratumumab and hyaluronidase-fihj) ...
Dr. Dan Thomson shares essential tips for injections, needle selection and syringe maintenance to ensure herd health and carcass quality.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results